INT210154

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.09
First Reported 2007
Last Reported 2007
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 1
Disease Relevance 0.23
Pain Relevance 0.03

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

cell-cell signaling (TXN, FASLG) signal transduction (TXN, FASLG) extracellular region (TXN, FASLG)
nucleoplasm (TXN) transport (TXN) mitochondrion (TXN)
TXN (Homo sapiens)
FASLG (Homo sapiens)
Pain Link Frequency Relevance Heat
Inflammation 8 51.84 Quite High
cytokine 3 50.00 Quite Low
rheumatoid arthritis 1 18.72 Low Low
Inflammatory response 1 6.96 Low Low
member 8 2 5.00 Very Low Very Low Very Low
agonist 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Lymphatic System Cancer 7 100.00 Very High Very High Very High
Apoptosis 4 75.20 Quite High
INFLAMMATION 9 51.84 Quite High
Infection 2 25.04 Quite Low
Autoimmune Disease 1 24.16 Low Low
Hypersensitivity 1 22.80 Low Low
Systemic Lupus Erythematosus 1 21.12 Low Low
Rheumatoid Arthritis 1 18.72 Low Low
Eczema 1 16.72 Low Low
Viral Infection 3 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
The presence of catalytically active Trx1 impeded CD30-dependent signaling in the YT lymphoma cell line, as demonstrated by its effect on CD25 and FasL expression, as well as its influence on cytotoxicity against Fas-expressing target cells.
Trx1 Regulation (effect) of Gene_expression (expression) of FasL associated with lymphatic system cancer
1) Confidence 0.09 Published 2007 Journal EMBO J Section Body Doc Link PMC1914094 Disease Relevance 0.23 Pain Relevance 0.03

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox